EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

BMT-CARE App: A Randomized Controlled Trial of a Psychosocial Digital Application for Caregivers of Patients Undergoing Hematopoietic Stem-Cell Transplantation

Jamie M Jacobs iD, Lara Traeger iD, Madison Freese, Anna Barata iD, Richard Newcomb iD, Dustin Rabideau iD, Nora Horick iD, Zachariah DeFilipp iD, Yi-Bin Chen iD, Tamryn Gray iD, Julia Pepper iD, Ella Caruso iD und 5 weitere

Journal of Clinical Oncology · 10.07.2025 · 43 (20) · 2265-2275

DOI: 10.1200/jco-25-00713 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Clinical Oncology, erschienen am 10.07.2025. Verfasst von Jamie M Jacobs und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Massachusetts General Hospital, Boston, MA. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Caregivers, Mobile Applications, Hematologic Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 63 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE Family and friend caregivers of patients undergoing hematopoietic stem-cell transplantation (HSCT) struggle with immense caregiving burden, leading to substantial quality of life (QOL) impairments and psychological distress. Yet, interventions to address caregivers' needs are limited. MATERIALS AND METHODS We conducted a randomized controlled trial of a psychosocial digital application (BMT-CARE App) versus usual care for adult caregivers of patients with hematologic malignancies undergoing HSCT. The BMT-CARE App included five modules combining psychoeducation and evidence-based behavior change strategies. Participants completed self-report measures at baseline and day 60 post-HSCT. The primary end point was QOL at day 60 assessed by the CareGiver Oncology QOL (CarGOQOL) measure. We also assessed caregiving burden (Caregiver Reaction Assessment), anxiety and depression symptoms (Hospital Anxiety and Depression Scale), and post-traumatic stress disorder (PTSD) symptoms (PTSD Checklist [PCL-5]). We used analysis of covariance adjusting for baseline scores to assess the effect of the intervention on study outcomes. RESULTS Between February 2023 and July 2024, we enrolled 125 of 174 approached caregivers (71.8%). Participants assigned to the BMT-CARE App used the app for a median of 146.9 minutes (range, 0-384.8). At day 60, BMT-CARE App caregivers reported clinically and significantly better QOL than those assigned to usual care (adjusted means = 76.3 v 69.9, P = .006). BMT-CARE App participants also reported significantly lower caregiving burden (11.2 v 12.3, P = .023), depression (3.8 v 5.6, P = .002), and PTSD symptoms (26.1 v 31.3, P = .012). The groups did not differ significantly in anxiety symptoms at day 60. CONCLUSION The BMT-CARE App led to significantly improved QOL, caregiving burden, depression, and PTSD symptoms among HSCT caregivers. This intervention should be tested in a multicenter study with a diverse HSCT caregiver population to determine generalizability and scalability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationCaregiversMobile ApplicationsHematologic NeoplasmsHumansMaleFemaleMiddle AgedQuality of LifeAdultAnxietyDepressionAgedStress Disorders, Post-Traumatic

Autor:innen und Institutionen

  • Department of Psychiatry, Massachusetts General Hospital, Boston, MA.
  • Harvard Medical School, Boston, MA.
  • University of Miami, Coral Gables, FL.
  • Department of Medicine, Massachusetts General Hospital, Boston, MA.
  • Biostatistics, Massachusetts General Hospital, Boston, MA.
  • University of North Carolina School of Nursing, Chapel Hill, NC.

ORCID-Profile: Jamie M Jacobs, Lara Traeger, Anna Barata, Richard Newcomb, Dustin Rabideau, Nora Horick, Zachariah DeFilipp, Yi-Bin Chen, Tamryn Gray, Julia Pepper, Ella Caruso, Hermioni L Amonoo, Stephanie J Lee, Joseph A Greer, Jennifer S Temel, Areej El-Jawahri

Zitieren

APA

Jacobs, J. M., Traeger, L., Freese, M., Barata, A., Newcomb, R., Rabideau, D., Horick, N., DeFilipp, Z., Chen, Y. B., Gray, T., Pepper, J., Caruso, E., Amonoo, H. L., Lee, S. J., Greer, J. A., Temel, J. S., & El-Jawahri, A. (2025). BMT-CARE App: A Randomized Controlled Trial of a Psychosocial Digital Application for Caregivers of Patients Undergoing Hematopoietic Stem-Cell Transplantation. Journal of Clinical Oncology, 43(20), 2265-2275. https://doi.org/10.1200/jco-25-00713

Vancouver

Jacobs JM, Traeger L, Freese M, Barata A, Newcomb R, Rabideau D, et al. BMT-CARE App: A Randomized Controlled Trial of a Psychosocial Digital Application for Caregivers of Patients Undergoing Hematopoietic Stem-Cell Transplantation. Journal of Clinical Oncology. 2025;43(20):2265-2275. doi:10.1200/jco-25-00713

BibTeX
@article{Jacobs2025,
  author = {Jacobs, Jamie M and Traeger, Lara and Freese, Madison and Barata, Anna and Newcomb, Richard and Rabideau, Dustin and Horick, Nora and DeFilipp, Zachariah and Chen, Yi-Bin and Gray, Tamryn and Pepper, Julia and Caruso, Ella and Amonoo, Hermioni L and Lee, Stephanie J and Greer, Joseph A and Temel, Jennifer S and El-Jawahri, Areej},
  title = {BMT-CARE App: A Randomized Controlled Trial of a Psychosocial Digital Application for Caregivers of Patients Undergoing Hematopoietic Stem-Cell Transplantation},
  journal = {Journal of Clinical Oncology},
  year = {2025},
  volume = {43},
  number = {20},
  pages = {2265--2275},
  doi = {10.1200/jco-25-00713}
}
Kostenlos starten →